Matches in Nanopublications for { ?s ?p "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP902401.RAQhaMyJJ9uYp8PlxYB2uhiBqLrWm2aw1tVUjCpFAhGoI130_assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902401.RAQhaMyJJ9uYp8PlxYB2uhiBqLrWm2aw1tVUjCpFAhGoI130_provenance.
- NP297733.RAXBQOcD1yhjeRgTXE-lWM3rT-thEsKVZKKeSIkhX9tXg130_assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297733.RAXBQOcD1yhjeRgTXE-lWM3rT-thEsKVZKKeSIkhX9tXg130_provenance.
- NP367580.RAAPicTgSW9cFb3kQxaz5ubZKkSOYsOVkrpToEvlGW3W0130_assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367580.RAAPicTgSW9cFb3kQxaz5ubZKkSOYsOVkrpToEvlGW3W0130_provenance.
- assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1351015.RAjy4nMKiS7crBeEnXoKq7uQWT4UvsJ_R3nEpJYxg8Krw130_assertion description "[Fibroblasts from HED patients had a two- to eightfold decrease in binding capacity for (125)I-labeled EGF, a decreased expression of the immunoreactive 170-kD EGF receptor (EGFR) protein, and a corresponding reduction in EGFR mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1351015.RAjy4nMKiS7crBeEnXoKq7uQWT4UvsJ_R3nEpJYxg8Krw130_provenance.